RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.

Related Reports

Market Research Reports provided by reports.iptechex.com
Bladder Cancer Therapy Area Pipeline Report
Nov 2010 - 172 pages - $1,495
Overactive Bladder Therapy Area Pipeline Report
Nov 2010 - 253 pages - $1,495
Successes and Failures for Avastin (Bevacizumab) mean Mixed News for the Blockbuster Drug in the Oncology Therapeutics Market
May 2011 - 7 pages - $500
Iressa (Bladder Cancer) - Analysis and Forecast to 2020
Oct 2011 - 21 pages - $2,000
Bladder Cancer - Pipeline Assessment and Market Forecasts to 2017
Dec 2010 - 47 pages - $2,000
MVAC (Bladder Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 22 pages - $2,000
Valstar (Bladder Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 19 pages - $2,000
Hypoactive Bladder - Pipeline Review, Q4 2010
Nov 2010 - 50 pages - $500
Thiotepa (Bladder Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 21 pages - $2,000
Ellence (Bladder Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 24 pages - $2,000
More Related Market Research Reports >>>

Your selection

Industry sector
Drug delivery del
Topical del
Therapeutic target
Oncology del
Bladder cancer del
Development phase
Early Stage del

Browse By

Industry sector
Dermatological
Oral

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us